Divi's Laboratories Ltd. (DIVISLAB): Divi's Laboratories Share Price hits fresh 52-week high at Rs 9,080.80

Published: 27 August 2026 at 9:29 AM IST

Divi's Laboratories Share Price is Rs 9,080.80, up 0.73%, after a fresh 52-week high of Rs 9,148.05. Market capitalisation stands at Rs 2,30,426.73 crore.

Divi's Laboratories Share Price opened the session in positive territory and moved to a fresh 52-week high, with the stock finishing at Rs 9,080.80, up Rs 65.75 or 0.73% from the previous close of Rs 9,015.05. The session high of Rs 9,148.05 also marks the 52-week high, while market capitalisation stands at Rs 2,30,426.73 crore. For readers tracking Divi's Laboratories Share Price Today, the data confirms a fresh yearly high but does not establish a company-specific catalyst.

In Divi's Laboratories Stock News, the move is relevant because the stock is now trading near the top of its recent range after a day that began at Rs 9,020.45 and stayed within a narrow band, with the low also at Rs 9,020.45. The day’s turnover was Rs 6.91 crore. Univest is tracking the price event, the valuation backdrop and the healthcare sector context together so that readers can assess the stock with verified numbers rather than assumptions. Divi's Laboratories Share Price therefore enters the market's focus as a 52-week high story, a yearly high story and a stock analysis topic at the same time.

Divi's Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 9,080.8
Previous Close	Rs 9,015.05
Today's Move	+Rs 65.75 (+0.73%)
Open	Rs 9,020.45
High	Rs 9,148.05
Low	Rs 9,020.45
Turnover	Rs 6.91 crore
Market Capitalisation	Rs 2,30,426.73 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 9,080.8 versus the previous close of Rs 9,015.05, a rise of 0.73%. The stock opened at Rs 9,020.45, reached a high of Rs 9,148.05 and touched a low of Rs 9,020.45.

Divi's Laboratories Share Price today shows a clean arithmetic move: the stock rose Rs 65.75 from the previous close of Rs 9,015.05 to Rs 9,080.80. The day opened at Rs 9,020.45, touched Rs 9,148.05, and did not trade below the opening level, which kept the session range compact. The fresh 52-week high is Rs 9,148.05, and the close sits Rs 67.25 below that peak. The day’s turnover was Rs 6.91 crore, which gives readers a factual sense of the day’s traded value. For anyone following Divi's Laboratories Share Price Update, the key point is simple: the stock set a new yearly high and held most of that gain into the close.

The move is also relevant for those searching Divi's Laboratories Share Price Today and Divi's Laboratories Share News because it places the stock in the 52 Week High Stocks conversation on Indian Stock Market screens. Univest notes the event as price action first: current price, previous close, day open, day low, day high and turnover all line up to confirm the fresh high. The next step in analysis is to place that price event against valuation and business quality, which is where Divi's Laboratories Share Price becomes more informative than the headline move alone.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,30,426.73 crore
P/E Ratio	81.82x
P/B Ratio	13.55x
ROE	16.19%
ROCE	21.51%
EPS	Rs 110.18
Book Value Per Share	Rs 665.36
Dividend Yield	0.33%

Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 81.82x, P/B 13.55x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.

Divi's Laboratories Ltd. has a market capitalisation of Rs 230426.73 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 81.82x, P/B at 13.55x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.33%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	81.82x
Benchmark Median P/E	30.54x
Benchmark Average P/E	46.96x
Benchmark P/E Range	3.19x to 671.51x
Company P/B Ratio	13.55x
Benchmark Median P/B	2.76x
Company ROE	16.19%
Benchmark Median ROE	11.83%
Company ROCE	21.51%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 2,30,426.73 crore
Benchmark Median Market Cap	Rs 623.8 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 81.82x, which is above the benchmark median of 30.54x, a difference of +167.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.83%, a difference of +36.86%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.75%, a difference of +56.44%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,87,140.99	85.25	20.71	26.76	19.27
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,59,952.51	37.71	5.27	14.85	19.11
Cipla Ltd.	CIPLA	1,14,715.15	33.76	3.24	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,717.93	25.37	4.25	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,00,768.23	93.3	18.09	18.31	18.2

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 81.82x compared with the displayed peer median of 37.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,30,426.73 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories

• Divi's Laboratories Share Price closed at Rs 9,080.80 after touching a fresh 52-week high of Rs 9,148.05.
• The day’s move was Rs 65.75, equal to 0.73% from the previous close of Rs 9,015.05.
• Market capitalisation stands at Rs 2,30,426.73 crore, placing the company well above the industry median.
• P/E is 81.82 and P/B is 13.55, both above the same-industry benchmark medians supplied in the data.
• ROE is 16.19% and ROCE is 21.51%, both above the benchmark medians for the same industry.

About Divi's Laboratories

Divi's Laboratories Ltd. operates in Healthcare, within the Pharmaceuticals & Drugs industry. The supplied financial history shows rising revenue and net profit across the latest reported quarters, while the balance-sheet asset base also increased in the available annual data. Divi's Laboratories Share Price is therefore tied to a company profile that is supported by earnings, book value, EPS and return ratios in the dataset. Univest keeps this section factual and limited to the verified company overview.

Track Divi's Laboratories Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

For users comparing Divi's Laboratories Share Price with broader market activity, Univest also helps scan the Indian Stock Market for stock updates, stock news and market moves without relying on unsupported interpretation. That makes the page useful for monitoring Divi's Laboratories Share Price Today, Divi's Laboratories Stock News and Divi's Laboratories Company News together.

Frequently Asked Questions

What is Divi's Laboratories Share Price today?

Ans. Divi's Laboratories Share Price is Rs 9,080.80, up Rs 65.75 or 0.73% from the previous close of Rs 9,015.05. The stock also touched a fresh 52-week high of Rs 9,148.05.

Did Divi's Laboratories hit a fresh 52-week high?

Ans. Yes. Divi's Laboratories Share Price touched Rs 9,148.05 during the session, which is the fresh 52-week high in the supplied data. The close was Rs 9,080.80, slightly below that peak.

What was Divi's Laboratories' day move?

Ans. The stock rose Rs 65.75, which equals 0.73% for the day. It opened at Rs 9,020.45, matched the day low at Rs 9,020.45 and reached Rs 9,148.05 at the high.

What is Divi's Laboratories market capitalisation?

Ans. Divi's Laboratories has a market capitalisation of Rs 2,30,426.73 crore. That places it well above the same-industry median market capitalisation of Rs 623.8 crore in the supplied benchmark set. The company operates in the Healthcare sector.

How does Divi's Laboratories compare on valuation?

Ans. Divi's Laboratories Share Price is backed by a P/E ratio of 81.82 and a P/B ratio of 13.55. Both are above the same-industry medians of 30.54 and 2.76, respectively. The company trades at a P/E ratio of 81.82x.

What do Divi's Laboratories ROE and ROCE show?

Ans. ROE is 16.19% and ROCE is 21.51%. Both are above the benchmark medians of 11.83% and 13.75% in the supplied same-industry comparison, which adds context to Divi's Laboratories Share Price.

What are the latest earnings and revenue figures?

Ans. The supplied figures show revenue of Rs 30,800 crore in Jun 2026 and net profit of Rs 9,020 crore in Jun 2026. Earlier figures also show a rising sequence across the recent quarters.

What is the dividend yield for Divi's Laboratories?

Ans. The supplied dividend yield is 0.33%. It is a factual yield metric based on the current price and historical payout data, and it should be read alongside EPS and book value.

Which healthcare peers are listed in the data?

Ans. The peer set includes Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences and Laurus Labs. Their valuation and return ratios help place Divi's Laboratories Share Price within the Healthcare industry context.